| Primary |
| Product Used For Unknown Indication |
23.1% |
| Ill-defined Disorder |
15.4% |
| Lymphoma |
15.4% |
| Body Temperature Increased |
7.7% |
| Herpes Zoster |
7.7% |
| Insomnia |
7.7% |
| Oropharyngeal Pain |
7.7% |
| Pyrexia |
7.7% |
| Varicella |
7.7% |
|
| Stevens-johnson Syndrome |
33.3% |
| Vaginal Inflammation |
33.3% |
| Varicella |
33.3% |
|
| Secondary |
| Plasma Cell Myeloma |
31.6% |
| Status Epilepticus |
21.1% |
| Porphyria Acute |
15.8% |
| Product Used For Unknown Indication |
15.8% |
| 5Q Minus Syndrome |
5.3% |
| Amyloidosis |
5.3% |
| Herpes Simplex Hepatitis |
5.3% |
|
| Platelet Count Decreased |
16.7% |
| Deep Vein Thrombosis |
8.3% |
| Dry Mouth |
8.3% |
| Heart Rate Decreased |
8.3% |
| Muscle Spasms |
8.3% |
| Myoclonus |
8.3% |
| Pain In Extremity |
8.3% |
| Plasma Cell Myeloma Recurrent |
8.3% |
| Thrombosis |
8.3% |
| Viraemia |
8.3% |
| Weight Decreased |
8.3% |
|
| Concomitant |
| Plasma Cell Myeloma |
60.1% |
| Chronic Lymphocytic Leukaemia |
8.5% |
| Bone Marrow Conditioning Regimen |
5.5% |
| Systemic Lupus Erythematosus |
4.8% |
| Stem Cell Transplant |
4.1% |
| Acute Lymphocytic Leukaemia |
2.6% |
| Myelodysplastic Syndrome |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Pancreatic Carcinoma |
1.5% |
| Prophylaxis Against Graft Versus Host Disease |
1.5% |
| Chronic Myeloid Leukaemia |
1.1% |
| Multiple Sclerosis |
1.1% |
| Acute Myeloid Leukaemia |
0.7% |
| Chemotherapy |
0.7% |
| Gait Disturbance |
0.7% |
| Lymphoma |
0.7% |
| Non-small Cell Lung Cancer Stage Iiia |
0.7% |
| Pain |
0.7% |
| Rheumatoid Arthritis |
0.7% |
| Actinic Keratosis |
0.4% |
|
| White Blood Cell Count Decreased |
14.4% |
| Epstein-barr Viraemia |
8.1% |
| Plasma Cell Myeloma |
7.2% |
| Pneumonia |
6.3% |
| Thrombosis |
6.3% |
| Vomiting |
6.3% |
| Neuropathy Peripheral |
5.4% |
| Pyrexia |
5.4% |
| Thrombocytopenia |
5.4% |
| Deep Vein Thrombosis |
4.5% |
| Pancytopenia |
4.5% |
| Platelet Count Decreased |
3.6% |
| Pulmonary Embolism |
3.6% |
| Death |
2.7% |
| Diarrhoea |
2.7% |
| Fatigue |
2.7% |
| Hypertension |
2.7% |
| Neutropenia |
2.7% |
| Rash |
2.7% |
| Swelling Face |
2.7% |
|
